Cellumed Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellumed Co Ltd with three other
companies in this sector in South Korea:
ISU Abxis Company Limited
sales of 19.46 billion Korean Won [US$18.00 million]
of which 100%
was Antibody Medicine),
(18.09 billion Korean Won [US$16.74 million]
of which 85%
was The clinical trial agent), and
(12.10 billion Korean Won [US$11.20 million]
Cellumed Co Ltd reported sales of 21.61 billion Korean Won (US$19.99 million)
December of 2017.
increase of 120.2%
versus 2016, when the company's sales were 9.81 billion Korean Won.